Mesenchymal Stem Cell-Based Therapy for Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Analysis of Randomized Controlled Trials.
Mesenchymal Stem Cell-Based Therapy for Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Analysis of Randomized Controlled Trials Authors: Dr. Shekhar Ingle and Team, Doctor's Forum for All π₯ Copyright: © 2026 Dr. Shekhar Ingle and Team, Doctor's Forum for All. All rights reserved. Corresponding Author: Dr. Shekhar Ingle Disclaimer: This article is for educational and clinical reference purposes only. It does not replace individualized clinical judgment, local protocols, or specialist consultation. Abstract Background: Diabetes mellitus is a metabolic disorder with no cure. Insulin therapy manages the symptoms. It doesn't fix the underlying problem. Mesenchymal stem cells (MSCs) have emerged as a potential disease-modifying therapy. They modulate the immune system. They repair damaged tissue. They might preserve beta-cell function. The promise is real. The evidence is growing. But is it ready for routine practice? Objective: This systematic review and analysi...